Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 6/2023

Open Access 29-04-2023 | Climate Change | Original Article

Cost awareness amongst irish ophthalmologists

Author: Barry Power

Published in: Irish Journal of Medical Science (1971 -) | Issue 6/2023

Login to get access

Abstract

Background

Healthcare systems have increasingly limited and stretched budgets. Clinicians have a key role in budget allocation. Awareness of the costs of high-use clinical items is important.

Aims

Assess awareness of the cost of commonly utilised clinical items amongst Irish Ophthalmologists

Methods

Irish ophthalmologists were contacted and asked to fill out an anonymous survey. We assessed knowledge of hospital costs of surgical materials, medications and anti VEGF drugs as well as retail pharmacy costs of commonly prescribed medications. The cost of items to the hospital was recorded from pharmacy and ward order receipts from a single university hospital. The costs of items to the patient were calculated by taking an average of 3 prices charged by local retail pharmacies. For each estimate we calculated the absolute error from the true price. We calculated the mean absolute errors (MAE) and percentage errors (MAPE) across the different groups.

Results

We received responses from 47 participants (15 Senior House Officers, 11 Registrars, 21 Consultant/Community Ophthalmologists). Despite 70% of respondents agreeing that the cost of an item should have a major role in its use, the average estimate was 124% inaccurate. Less than 50% of responses were within 50% of the true cost of the item. Self-perceived knowledge was acknowledged to be limited or very limited in 73% of responses.

Conclusions

We demonstrate variable and limited levels of cost awareness. Seniority and better self-perceived knowledge were not found to be associated with better estimate accuracy.
Literature
2.
go back to reference Hillman A, Nash D, Kissick W et al (1986) Managing the medical-industrial machine. NEMJ 315:511–13 Hillman A, Nash D, Kissick W et al (1986) Managing the medical-industrial machine. NEMJ 315:511–13
5.
go back to reference Cox ER, Jernigan C, Coons SJ et al (2001) Medicare beneficiaries' management of capped prescription benefits. Med Care 39:296–301CrossRefPubMed Cox ER, Jernigan C, Coons SJ et al (2001) Medicare beneficiaries' management of capped prescription benefits. Med Care 39:296–301CrossRefPubMed
6.
go back to reference Spence MM, Hui R, Chan J (2006) Cost reduction strategies used by elderly patients with chronic obstructive pulmonary disease to cope with a generic-only pharmacy benefit. J Manag Care Pharm. 12:377–382PubMed Spence MM, Hui R, Chan J (2006) Cost reduction strategies used by elderly patients with chronic obstructive pulmonary disease to cope with a generic-only pharmacy benefit. J Manag Care Pharm. 12:377–382PubMed
7.
go back to reference Piette JD, Heisler M, Wagner TH (2004) Cost-related medication underuse: Do patients with chronic illnesses tell their doctors? Arch Intern Med. 164:1749–1755CrossRefPubMed Piette JD, Heisler M, Wagner TH (2004) Cost-related medication underuse: Do patients with chronic illnesses tell their doctors? Arch Intern Med. 164:1749–1755CrossRefPubMed
9.
go back to reference Barclay LP, Hatton RC, Doering PL et al (1995) Physicians' perceptions and knowledge of drug costs: results of a survey. Formulary 30:268-70, 272, 277-9 Barclay LP, Hatton RC, Doering PL et al (1995) Physicians' perceptions and knowledge of drug costs: results of a survey. Formulary 30:268-70, 272, 277-9
11.
go back to reference Bade K, Hoogerbrug J (2015) Awareness of surgical costs: A multicenter cross-sectional survey. J Surg Educ 2(1):23–27CrossRef Bade K, Hoogerbrug J (2015) Awareness of surgical costs: A multicenter cross-sectional survey. J Surg Educ 2(1):23–27CrossRef
13.
go back to reference Chakravarthy U, Harding SP, Rogers CA et al (2013) Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet 382(9900):1258-67. https://doi.org/10.1016/S0140-6736(13)61501-9. Epub 2013 Jul 19. PMID: 23870813 Chakravarthy U, Harding SP, Rogers CA et al (2013) Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet 382(9900):1258-67. https://​doi.​org/​10.​1016/​S0140-6736(13)61501-9. Epub 2013 Jul 19. PMID: 23870813
14.
15.
go back to reference Scott IU, VanVeldhuisen PC, Ip MS et al, SCORE2 Investigator Group (2017) Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial. JAMA 317(20):2072-2087. https://doi.org/10.1001/jama.2017.4568. PMID: 28492910; PMCID: PMC5710547 Scott IU, VanVeldhuisen PC, Ip MS et al, SCORE2 Investigator Group (2017) Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial. JAMA 317(20):2072-2087. https://​doi.​org/​10.​1001/​jama.​2017.​4568. PMID: 28492910; PMCID: PMC5710547
Metadata
Title
Cost awareness amongst irish ophthalmologists
Author
Barry Power
Publication date
29-04-2023
Publisher
Springer International Publishing
Keyword
Climate Change
Published in
Irish Journal of Medical Science (1971 -) / Issue 6/2023
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-023-03332-7

Other articles of this Issue 6/2023

Irish Journal of Medical Science (1971 -) 6/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine